ARCHIVES

LDK378 Demonstrates 58 Percent Overall Response Rate in Phase I

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

Momentum Continues For Private Development Of Free Standing Cancer Centers

July 19, 1985

Anastrozole Better Than Tamoxifen For HR+ Postmenopausal Breast Cancer, Study Finds

May 27, 2005

NCI considers allowing some centers to opt out of site visits.

March 19, 2004

NCI Programs: Advisors Approve Recompetition of Phase II Contracts

July 9, 1999

Scientists Glimpse Cellular Machines Inside Living Cells; Funding Opportunities

November 22, 2002

In Brief: NVI Delays Release Of Laetrile Study Result; DCCRC’s New Name: Div. Of Extramural Affairs

August 25, 1978